EESTech, Inc.
EESHSync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on EESH.
7-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-Q ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ |
|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) | — |
-99.2%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-3405%)
|
768.2%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+25506%)
|
— | — | — | — |
| EPS Growth YoY (%) |
0.0%
Caution
Caution
Year-over-year change in earnings per share
Optimal:
> 10%
|
— |
0.0%
Caution
Caution
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — |
| Net Income Growth YoY (%) |
20.2%
Good
↑
Good
Improving
Year-over-year change in net income |
-127.4%
Weak
Weak
Year-over-year change in net income |
10.0%
Fair
Fair
Year-over-year change in net income |
— | — | — | — |
| FCF Growth YoY (%) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-Q ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ |
|---|---|---|---|---|---|---|---|
| Operating Margin (%) (%) | — | — |
-200.4%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1102%)
|
— | — |
-320.7%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1703%)
|
— |
| Profit Margin (%) (%) | — | — |
-200.4%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1770%)
|
— | — |
-320.7%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-2772%)
|
— |
| FCF Margin (%) (%) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF / Net Income (x) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-Q ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ |
|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
-42.6%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-43.4%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-17.9%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — | — |
| Return on Capital (%) (%) |
-265.7%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-311.8%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-49.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — |
| Return on Common Equity (%) (%) |
-53.9%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-639%)
|
-54.9%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-649%)
|
-22.6%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-326%)
|
— | — | — | — |
| Metric | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-Q ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ |
|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $-572.58K | $-458.75K | $-91.00K | $135.26K | — | — | — |
| Total Equity (USD) | $623.96K | $715.69K | $1.07M | $1.26M | — | — | — |
| Metric | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-Q ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ |
|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | — | $452.00 | $120.34K | — | $84.26K | $53.88K | $13.86K |
| Net Income, GAAP (USD) | $-336.61K | $-392.93K | $-241.12K | — | $-421.65K | $-172.77K | $-267.99K |
| Operating Cash Flow (USD) | $-152.60K | $-308.18K | $-298.96K | — | $-494.51K | $-203.12K | $-199.21K |
Secondary lens
Benchmark Lens
Compare EESH against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare EESH against peers after checking the statement evidence.
Compare EESH with peers
Stack EESH against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago